APA (7th ed.) Citation

W, A., A, J., D, V., B, C., S, B., M, B., . . . KJ, S. (2025). CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL. Blood, 145(6), 590. https://doi.org/10.1182/blood.2024025725

Chicago Style (17th ed.) Citation

W, Alduaij, et al. "CNS Relapse in High-grade B-cell Lymphoma with MYC and BCL2 Rearrangements and Dark-zone Signature-expressing DLBCL." Blood 145, no. 6 (2025): 590. https://doi.org/10.1182/blood.2024025725.

MLA (9th ed.) Citation

W, Alduaij, et al. "CNS Relapse in High-grade B-cell Lymphoma with MYC and BCL2 Rearrangements and Dark-zone Signature-expressing DLBCL." Blood, vol. 145, no. 6, 2025, p. 590, https://doi.org/10.1182/blood.2024025725.